SCHEMBL9817124

SCHEMBL9817124

COCCOCCOCCCCl

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.34
CYP3A4 P08684 1/20 0.34
CA2 P00918 2/20 0.34
CA1 P00915 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MEN1 O00255 1/20 0.31
THRB P10828 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9817087 1.00 TSHR (0.34) TSHRCYP3A4CA2CA1TDP1
SCHEMBL17070883 0.90 MEN1 (0.38) TSHRCYP3A4CA2ALDH1A1MEN1
SCHEMBL8704616 0.90 CA1 (0.30) CA2CA1
SCHEMBL25921552 0.90 MEN1 (0.38) TSHRCYP3A4CA2ALDH1A1MEN1
SCHEMBL1727003 0.85 TSHR (0.43) TSHRCYP3A4CA2CA1TDP1
SCHEMBL8958353 0.85 TSHR (0.43) TSHRCYP3A4CA2CA1TDP1
SCHEMBL25220010 0.82 CA2 (0.37) CA2ALDH1A1
SCHEMBL5376990 0.82 CA2 (0.37) CA2ALDH1A1
SCHEMBL16106544 0.82 CA2 (0.37) CA2ALDH1A1
SCHEMBL5377576 0.82 CA2 (0.37) CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103360421-A Making method of high purity sulfydryl silicane compound DAISO CO LTD 2013-10-23 CN claimed
CN-103360421-A Making method of high purity sulfydryl silicane compound DAISO CO LTD 2013-10-23 CN disclosed
EP-0190042-B1 ORGANIC COMPOUNDS AND THEIR PHARMACEUTICAL USE Lilly Industries Limited (GB) 1991-10-30 EP disclosed
US-4675335-A LEUKOTRIENE ANTAGONISTS LILLY INDUSTRIES LIMITED (GB) 1987-06-23 US disclosed
EP-0190042-A2 Organic compounds and their pharmaceutical use Lilly Industries Limited (GB) 1986-08-06 EP disclosed